FONAR Corporation (FONR)

CIK 0000355019 · Healthcare · Diagnostics and Research

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q3-2026 8-K (2026-05-12) · 99.1  |  8-K (2026-02-17) · 99.1
Q2-2026 8-K (2025-11-12) · 99.1
Q1-2025 8-K (2024-11-12) · 99.1  |  8-K (2024-09-30) · 99.1
Latest FY-2025 8-K (2025-09-12) · 99.1  |  8-K (2025-05-19) · 99.1
Q3-2025 —
Q2-2025 8-K (2025-02-19) · 99.1
Q1-2025 8-K (2024-11-12) · 99.1  |  8-K (2024-09-30) · 99.1
FY-2024 8-K (2024-05-16) · 99.1
Q3-2024 8-K (2024-02-15) · 99.1
Q2-2024 8-K (2023-11-15) · 99.1
Q1-2024 8-K (2023-09-29) · 99.1
FY-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Income
Consolidated Statements of Operations
Condensed Consolidated Statements of Income (unaudited) (P)
—
Consolidated Statements of Changes In Equity
Consolidated Statements of Stockholders' Equity
—
Consolidated Statements of Cash Flows
Notes
Accounts Receivable, Medical Receivable and Management and Other Fees Receivable
Allowance For Doubtful Accounts
—
Capital Stock
—
Commitments and Contingencies
Controlling and Noncontrolling Interests
—
Cybersecurity Risk Management and Strategy Disclosure
—
Description of Business and Basis of Presentation
—
Description of Business and Liquidity and Capital Resources
—
Income Taxes
Insider Trading Arrangements
Inventories
Long-term Debt, Notes Payable and Capital Leases
—
Operating & Financing Leases
Operating and Finance Leases
—
Operating and Financing Leases
—
Other Current Liabilities
Other Intangible Assets
Pay Vs Performance Disclosure
Property and Equipment
Related Party Transactions
Segment and Related Information
Subsequent Events
Summary of Significant Accounting Policies
Supplemental Cash Flow Information